Does Mounjaro Burn Muscle — and What Can You Do About It?

Rapid weight loss from any cause (diet, surgery, or medication) carries some risk of lean-mass reduction alongside fat loss.
In tirzepatide trials, the dominant component of weight lost was fat mass, not muscle, particularly in participants who maintained protein intake and activity.
Resistance exercise and adequate dietary protein are the two most evidence-backed strategies for preserving muscle during weight loss treatment.
If you notice unexplained weakness or significant muscle symptoms, speak to your prescriber before adjusting anything yourself.

Mounjaro does not specifically target muscle, but like any significant calorie deficit, weight loss on tirzepatide can include some lean mass alongside fat. Clinical trial data show the vast majority of weight lost is fat mass, particularly with adequate protein and activity. That said, this is a real question worth taking seriously, not dismissing. These are prescription-only medicines assessed individually by a clinician, and how your body responds depends on factors your prescriber will consider with you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence tells us about tirzepatide, fat loss, and lean mass

Does losing weight quickly mean losing muscle?

It is a reasonable concern. When the body is in a sustained calorie deficit, it draws on stored energy, and that includes some protein from muscle tissue, not just fat. This happens with crash diets, bariatric surgery, and weight-loss medicines alike. The question for Mounjaro specifically is how large that lean-mass component tends to be, and what influences it.

The honest answer is that the composition of weight lost depends on several things: how fast you lose, how much protein you eat, whether you do any resistance or strength-based activity, and your starting muscle mass. Mounjaro works by acting on two gut-hormone receptors (GIP and GLP-1) to reduce appetite substantially. That reduction in food intake is what drives weight loss, and a sharper appetite suppression can mean a steeper deficit, which is why the question of whether Mounjaro causes muscle loss matters more here than with slower interventions.

There is no evidence that tirzepatide, the active ingredient in Mounjaro, chemically degrades muscle tissue. The concern is indirect: less food in generally means less protein in, and a bigger deficit means the body leans more on stored tissues. Keeping protein intake deliberate during treatment is one of the simplest things you can act on straight away.

What did the Mounjaro trials actually find about body composition?

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised over 2,500 adults with obesity and showed average body-weight reductions of around 20–21% at the 15mg dose over 72 weeks. Sub-studies of SURMOUNT trials that measured body composition using DEXA scans found that the large majority of mass lost was fat mass. Lean mass reduction did occur but represented a smaller share of total weight lost than fat — a pattern broadly consistent with other GLP-1 class medicines and with lifestyle-only programmes of similar duration.

That said, if you are losing 20% of your body weight, even a modest percentage represented by lean tissue is a real amount of muscle in absolute terms. This is why researchers and clinicians increasingly emphasise that treatment is not just about the number on the scales. Our overview of Mounjaro and muscle loss covers the body-composition evidence in more depth, including what the sub-study data showed for participants who also did structured exercise.

The practical check most people can do in under a minute: track your grip strength periodically using a doorknob jar, or more simply, note whether everyday lifting tasks feel harder than they did a month ago. A noticeable, progressive drop in functional strength is worth raising with your prescriber, not waiting out.

Does tirzepatide burn fat differently from other weight-loss treatments?

There is emerging evidence that the dual GIP and GLP-1 mechanism in tirzepatide may favour fat oxidation to a greater degree than single-pathway GLP-1 medicines, though this research is still being built out in peer-reviewed literature. What the licensed-indication evidence does confirm is that tirzepatide produces greater average weight loss than semaglutide 2.4mg, as shown in the SURMOUNT-5 head-to-head trial. Whether that translates to a better muscle-sparing ratio at the same level of weight loss is a separate question that ongoing body-composition research is addressing. You can read more about how Mounjaro compares on the fat-loss side in our explainer on how Mounjaro affects fat tissue.

What is clear from the NHS guidance on weight-management injections is that these medicines are intended to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone intervention. That wraparound approach is not just a regulatory formality; it is the mechanism by which muscle is protected. NHS England's guidance on weight-management injections explicitly addresses the importance of dietary support during treatment.

What can you actually do to protect muscle while on Mounjaro?

Three things come up consistently in the clinical literature and in what our prescribers discuss with patients. First, protein: aim to keep it a deliberate priority even as overall appetite falls. When food volume drops sharply, protein is often the first macronutrient to get squeezed out in favour of whatever is most palatable. Second, resistance training: it does not need to be a gym programme. Bodyweight exercises at home two or three times a week give the muscles a reason to hold on. Third, pace: very rapid weight loss tends to include more lean mass than a steadier trajectory. Titrating through doses carefully, rather than rushing to the highest tolerated dose, supports this, though titration decisions always sit with your prescriber.

If you are experiencing muscle pain or aching alongside weight loss on Mounjaro, that is a separate symptom worth discussing with your clinical team, it can have several causes and is not simply a marker of muscle being burned. For a broader look at whether Mounjaro makes you lose muscle, including what prescribers weigh up when supporting patients through treatment, the evidence picture is more nuanced than the headline concern suggests.

Mounjaro is a prescription medicine, and whether it is appropriate for you depends on a full clinical assessment. If you would like to understand how our prescribers approach body composition and lifestyle support as part of treatment, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions